Pacific Biosciences Of California (PACB) Share-based Compensation Growth (1y) (2011 - 2026)
Pacific Biosciences Of California (PACB) Share-based Compensation Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 7.56% |
| 10 | Pacific Biosciences Of California | 419.38 Mn | 182.51 Mn | 12.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -84.92% |
| Dec 31, 2025 | -86.50% |
| Sep 30, 2025 | 129.89% |
| Jun 30, 2025 | -149.24% |
| Mar 31, 2025 | 51.47% |
| Dec 31, 2024 | 328.34% |
| Sep 30, 2024 | -286.60% |
| Jun 30, 2024 | -3.76% |
| Mar 31, 2024 | 8.76% |
| Dec 31, 2023 | -7.64% |
| Sep 30, 2023 | 455.77% |
| Jun 30, 2023 | 2,009.79% |
| Mar 31, 2023 | -20.93% |
| Dec 31, 2022 | -58.47% |
| Sep 30, 2022 | -81.25% |
| Jun 30, 2022 | -94.63% |
| Mar 31, 2022 | 123.34% |
| Dec 31, 2021 | 34.32% |
| Sep 20, 2021 | 278.61% |
| Jun 30, 2021 | 2,416.72% |